Results 151 to 160 of about 128,101 (191)

BET-bromodomain Inhibitor ODM-207 [PDF]

, 2020
openaire   +1 more source

Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types.

Am J Physiol Regul Integr Comp Physiol
Jones Lipinski RA, Stancill JS, Nuñez R, Wynia-Smith SL, Sprague DJ, Nord JA, Bird A, Corbett JA, Smith BC.   +8 more
europepmc   +1 more source

Zaiken MC, Flynn R, Paz KG, et al. BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood. 2022;139(19):2983-2997.

Blood, 2023
europepmc   +1 more source

BET Bromodomain Inhibitor ZEN-3694 [PDF]

, 2020
openaire   +1 more source

Developing chemical probes for the BET bromodomains

, 2016
Hewings, D, Wang, M, Philpott, M, Fedorov, O, Uttarkar, S, Filippakopoulos, P, Picaud, S, Vuppusetty, C, Marsden, B, Heightman, T, Knapp, S, Brennan, P, Conway, S   +12 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

BET bromodomain inhibitors

Current Opinion in Chemical Biology, 2022
Lysine acetylation creates docking sites for epigenetic reader domains of BET bromodomain proteins that have emerged as principal regulators of linage specific gene transcription. The development of potent and highly selective inhibitors, that have been soon widely available, enabled mechanistic studies in a diversity of disease models leading to a ...
Stefan Knapp, Martin Peter Schwalm
exaly   +3 more sources